Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials.

Neuropsychopharmacology · 2012 · PMC3260990 · PMID 22048466

Europe PMC DOI

hedged sentence

0.2000

closest p · 4.0× alpha

0.2000

boldest claim

The sentences

marginally significantp <0.20not close (p > 0.1)

For markers with at least marginally significant interaction with treatment ( p <0.20), the analysis was performed for each treatment group separately, as well as for all subjects together and adjusted for treatment.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.